Characterization of immortalized bone marrow erythroid progenitor adult (imBMEP-A)—The first inducible immortalized red blood cell progenitor cell line derived from bone marrow CD71-positive cells

• Published in: Cytotherapy (Oxford, England) Vol. 26; no. 11; pp. 1362 - 1373
• Main Authors: Kronstein-Wiedemann, Romy, Thiel, Jessica, Sürün, Duran, Teichert, Madeleine, Künzel, Stephan R., Zimmermann, Stefan, Wagenführ, Lisa, Buchholz, Frank, Tonn, Torsten
• Format: Journal Article
• Language: English
• Published: England Elsevier Inc 01.11.2024
• Subjects: Antigens, CD - metabolism; Blood pharming; Bone Marrow Cells - cytology; Bone Marrow Cells - metabolism; Cell Differentiation; Cell Line; Erythrocyte; Erythrocytes - cytology; Erythrocytes - metabolism; Erythroid Precursor Cells - cytology; Erythroid Precursor Cells - metabolism; Erythropoiesis; Humans; Receptors, Transferrin - metabolism; Reticulocytes - cytology; Reticulocytes - metabolism; Transfusion; Universal blood; Erythrocyte; Blood pharming; Cell line; Transfusion; Universal blood
• ISSN: 1465-3249; 1477-2566; 1477-2566
• DOI: 10.1016/j.jcyt.2024.06.009

Ex vivo production of red blood cells (RBCs) represents a promising alternative for transfusion medicine. Several strategies have been described to generate erythroid cell lines from different sources, including embryonic, induced pluripotent, and hematopoietic stem cells. All these approaches have in common that they require elaborate differentiation cultures whereas the yield of enucleated RBCs is inefficient. We generated a human immortalized adult erythroid progenitor cell line derived from bone marrow CD71-positive erythroid progenitor cells (immortalized bone marrow erythroid progenitor adult, or imBMEP-A) by an inducible expression system, to shorten differentiation culture necessary for terminal erythroid differentiation. It is the first erythroid cell line that is generated from direct reticulocyte progenitors and demonstrates robust hemoglobin production in the immortalized state. Morphologic analysis of the immortalized cells showed that the preferred cell type of the imBMEP-A line corresponds to hemoglobin-producing basophilic erythroblasts. In addition, we were able to generate a stable cell line from a single cell clone with the triple knockout of RhAG, RhDCE and KELL. After removal of doxycycline, part of the cells differentiated into normoblasts and reticulocytes within 5–7 days. Our results demonstrate that the imBMEP-A cell line can serve as a stable and straightforward modifiable platform for RBC engineering in the future. [Display omitted]